Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Fertility Drugs Market In 2029?
The market size for fertility drugs has experienced significant expansion in the past years. It is set to rise from $3.13 billion in 2024 to $3.36 billion in 2025 with a Compound Annual Growth Rate (CAGR) of 7.3%. The unprecedented growth during the historical period can be related to rising infertility numbers, progress in the field of reproductive medicine, advancements in Assisted Reproductive Technologies (ART), and deferred childbearing.
What Growth Rate Is Forecasted for the Fertility Drugs Market by 2029?
The market size for fertility drugs is projected to witness notable expansion in the coming years, increasing to $4.39 billion in 2029 with a CAGR of 6.9%. The forecasted rise can be linked to an aging populace, lifestyle-related variables, assisted reproductive technologies (ART), and customized medicine. Key trends predicted during this period encompass progress in assisted reproductive technologies (ART), ovulation-stimulating drugs, and hormonal treatments.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2810&type=smp
Which Key Companies Are Shaping the Future of the Fertility Drugs Market?
Major companies operating in the fertility drugs market include Merck & Co., Ferring Pharmaceuticals Inc., Bayer AG, Berlex Laboratories Inc., Janssen Pharmaceutical Inc., Pfizer Inc., Novartis AG, Procter & Gamble Health Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Abbott Laboratories, Sanofi S.A., Eli Lilly and Company, Serono Inc., Novagen Healthcare Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Schering-Plough Corporation, Regeneron Pharmaceuticals Inc., F. Hoffmann-La Roche AG, Vitrolife, Cook Medical, Organon Group, The Cooper Companies Inc., Irvine Scientific, Genea Biomedx, Mankind Pharma
Which Factors Are Driving Demand in the Fertility Drugs Industry?
The escalating prevalence of infertility worldwide is propelling the expansion of the fertility drugs market. Defined as the incapacity to conceive after a year of consistent attempts, infertility has seen a significant increase. These fertility drugs are extensively employed to address infertility problems in both genders. The ascent in infertility cases is credited to physiological and hormone issues, as well as lifestyle and environmental factors. To resolve fertility issues in women, these drugs are utilized to manage ovulation cycles, impacting the sale of such medicines. For example, data from the UK’s Office for National Statistics asserts that the total fertility rate (TFR) declined to 1.49 children per woman in 2022, down from 1.55 in 2021. Consequently, the surge in infertility cases worldwide is boosting the need for fertility drugs, generating growth in the fertility drug market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=2810&type=smp
How Is the Fertility Drugs Market Segmented by Several Divisions?
The fertility drugs market covered in this report is segmented –
1) By Type Of Drug: Prescription Fertility Drugs, Over-The-Counter Fertility drugs
2) By Route of Administration: Oral, Intravenous, Subcutaneous, Intramuscular
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Prescription Fertility Drugs: Gonadotropins, Clomiphene Citrate, Letrozole, GnRH Agonists, GnRH Antagonists, Progesterone
2) By Over-The-Counter Fertility Drugs: Ovulation Predictor Kits, Fertility Supplements, Fertility Monitors
What are the Emerging Market Trends Driving the Growth of the Fertility Drugs Industry?
Top firms in the fertility drugs market are directing their efforts towards creating new and innovative solutions such as peptide-based injectable treatments aimed at improving reproductive health results. These treatments make use of synthetic or natural peptides to control or drive hormonal activities, especially in relation to fertility and reproductive health. Lupin Limited, a pharmaceutical firm based in India, for example, introduced a ganirelix acetate injection in the United States in February 2024. This drug is typically used in assisted reproductive technology (ART) procedures to halt premature ovulation while controlling ovarian stimulation in women opting for in vitro fertilization (IVF). Ganirelix acetate, a GnRH antagonist, assists in controlling hormone levels, enabling a more efficient management of ovarian stimulation. The US debut shows Lupin’s ongoing dedication to broaden their product range in the reproductive health market, and their emphasis on meeting the needs of patients seeking fertility treatments.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report
Which Regions Are Driving Growth in the Fertility Drugs Market?
The countries covered in the fertility drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2810
This Report Delivers Insight On:
1. How big is the fertility drugs market, and how is it changing globally?
2. Who are the major companies in the fertility drugs market, and how are they performing?
3. What are the key opportunities and risks in the fertility drugs market right now?
4. Which products or customer segments are growing the most in the fertility drugs market?
5. What factors are helping or slowing down the growth of the fertility drugs market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
